Prednisone Completed Phase 2 Trials for Glomerulonephritis minimal lesion / Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00001212Drug Therapy in Lupus Nephropathy
NCT00000421Serologically Active, Clinically Stable Systemic Lupus Erythematosus